Event Brief
Eli Lilly tops estimates, raises outlook on Zepbound
Filed: Apr 30, 2026 at 7:02 AM ET
Summary: Eli Lilly exceeded quarterly estimates and raised its full-year sales outlook as Zepbound and Mounjaro sales surged.
WHO: Eli Lilly
WHAT: Raised full-year sales outlook and adjusted profit guidance after strong Zepbound and Mounjaro sales
WHEN: Apr 30, 2026 at 6:51 AM ET
WHERE: Location not specified
WHY: No specific cause was reported.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
📋 This story has 2 earlier reports
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →